VIRMA and gastric cancer: KIAA1429 can reduce the sensitivity of liver cancer cells to the chemotherapy drug sorafenib and enhance the resistance of gastric cancer cells to oxaliplatin chemotherapy, thereby affecting the development of cancer (237).